Glycoside-plasma level under maintenance therapy--dispersion of the concentrations and its causes
Kuhlmann, J.; Rietbrock, N.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1704-1709
1976
ISSN/ISBN: 0070-4067 PMID: 1030086 Document Number: 98271
Document emailed within 1 workday
Related Documents
Schwarzfischer, V.P. 1976: Serum glycoside level in old age. Problems of course control in glycoside therapy Fortschritte der Medizin 94(14): 841-846Ochs, H.R.; Bodem, G.; Schlehbusch, H.; Nuppeney, M.; Baur, M.P.; Oberhoffer, G. 1978: The clinical significance of plasma glycoside concentrations in patients with cardiac pacemakers Zeitschrift für Kardiologie 67(2): 109-115
Weiss, W.; Olcay, A.; Teufel, W.; Glocke, M. 1975: Gycoside serum concentrations under maintenance therapy with Lanicor, Card-Lamuran, MF708d, and Lanitop Medizinische Klinik 70(35): 1367-1374
Preston, A.M.; Bercovitch, F.B.; Jimenez, B.D.; Rodriguez Orengo, J.F.; Morales, W.Delgado.; Rodriguez, C.A.; Lebron, M.R.; Rivera, C.E. 2002: Plasma homocysteine concentrations in a population of rhesus monkeys (Macaca mulatta): reference ranges and accompanying plasma concentrations of folate and vitamin B12 Contemporary Topics in Laboratory Animal Science 41(1): 28-30
Collart, F.; Staroukine, M.; Verniory, A. 1985: Relationships between blood pressure, heart rate and plasma epinephrine, norepinephrine, angiotensin II concentrations, plasma renin activity during chronic guanfacine therapy in patients with essential arterial hypertension Acta Cardiologica 40(3): 269-276
Reiser, M.; Salzberger, B.; Stiepel, A.; Hoetelmans, R.; Diehl, V.; Fätkenheuer, G. 1999: Virological efficacy and plasma drug concentrations of nelfinavir plus saquinavir as salvage therapy in HIV-infected patients refractory to standard triple therapy European Journal of Medical Research 4(2): 54-58
Ellis, C.N.; Fradin, M.S.; Hamilton, T.A.; Voorhees, J.J. 1995: Duration of remission during maintenance cyclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy Archives of Dermatology 131(7): 791-795
Miyauchi, Y.; Mii, Y.; Morishita, T.; Miura, S.; Honoki, K.; Aoki, M.; Kido, A.; Tamai, S.; Hino, M.; Nomura, Y.; Nakanishi, E. 1996: A device for rapid elevation of plasma methotrexate (MTX) concentration and its maintenance in high-dose MTX therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(5): 595-599
Hassan, M.; Ehrsson, H.; Smedmyr, B.; Tötterman, T.; Wallin, I.; Oberg, G.; Simonsson, B. 1989: Cerebrospinal fluid and plasma concentrations of busulfan during high-dose therapy Bone Marrow Transplantation 4(1): 113-114
Xiang, G-da.; Sun, H-ling.; Zhao, L-shuang.; Hou, J.; Yue, L. 2007: Changes in plasma concentrations of osteoprotegerin before and after levothyroxine replacement therapy in hypothyroid patients Zhonghua Yi Xue Za Zhi 87(30): 2121-2125
Murasawa, T.; Sakai, Y.; Sakai, S.; Ohtsuka, T.; Ohno, D.; Amitani, K-ichi.; Ono, T.; Munakata, K. 2008: QT dispersion increases during hemodialysis procedures in patients undergoing maintenance dialysis: association with an RA system and holter electrocardiogram Nihon Jinzo Gakkai Shi 50(4): 481-487
Riedel, E.; Nündel, M.; Algermissen, B.; Hampl, H.; Scigalla, P.; Stabell, U. 1989: Changes in the concentrations of hydroxyproline, glycine and serine in the plasma of haemodialysis patients undergoing erythropoietin therapy Journal of Clinical Chemistry and Clinical Biochemistry 27(11): 851-856
Kirmizibekmez, H.; Taşdemir, D.; Ersöz, T.; Ireland, C.M.; Caliş, I. 2002: A new pregnane glycoside and a furostanol glycoside from Digitalis cariensis Die Pharmazie 57(10): 716-720
Day, R.O.; Francis, H.; Vial, J.; Geisslinger, G.; Williams, K.M. 1995: Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations Journal of Rheumatology 22(12): 2295-2303
Lapicque, F.; Bertin, P.; Netter, P. 1996: Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations Journal of Rheumatology 23(10): 1826-7; Author Reply 1827-8
Baker, C.H.; Davis, D.L.; Sutton, E.T. 1979: Microvascular plasma velocity and indicator dispersion with hemorrhage Circulatory Shock 6(1): 61-74
Kubicek, F. 1983: Alternatives to glycoside therapy? Wiener Klinische Wochenschrift 95(17): 607-611
Na-Bangchang, K.; Vanijanonta, S.; Karbwang, J. 1995: Plasma concentrations of praziquantel during the therapy of neurocysticerosis with praziquantel, in the presence of antiepileptics and dexamethasone Southeast Asian Journal of Tropical Medicine and Public Health 26(1): 120-123
Dietmann, K. 1977: Glycoside therapy in coronary disease Wiener Medizinische Wochenschrift 127(20): 627-630
Rösner, K. 1979: Improvement of cardiac glycoside therapy Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 34(12): 337-338